MX387476B - Antibióticos de amplio espectro macrocíclico. - Google Patents

Antibióticos de amplio espectro macrocíclico.

Info

Publication number
MX387476B
MX387476B MX2018006199A MX2018006199A MX387476B MX 387476 B MX387476 B MX 387476B MX 2018006199 A MX2018006199 A MX 2018006199A MX 2018006199 A MX2018006199 A MX 2018006199A MX 387476 B MX387476 B MX 387476B
Authority
MX
Mexico
Prior art keywords
broad spectrum
compounds
macrocyclic antibiotics
spectrum macrocyclic
antibiotics
Prior art date
Application number
MX2018006199A
Other languages
English (en)
Spanish (es)
Other versions
MX2018006199A (es
Inventor
Cuong Q Ly
Huiyong Hu
Jacob Bradley Schwarz
James John Crawford
Michael F T Koehler
Peter Andrew Smith
Prasuna Paraselli
Robert I Higuchi
Tucker Curran Roberts
Yongsheng Chen
Zhiyong Yu
Original Assignee
Rqx Pharmaceuticals Inc
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rqx Pharmaceuticals Inc, Genentech Inc filed Critical Rqx Pharmaceuticals Inc
Publication of MX2018006199A publication Critical patent/MX2018006199A/es
Publication of MX387476B publication Critical patent/MX387476B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2018006199A 2015-11-20 2016-11-21 Antibióticos de amplio espectro macrocíclico. MX387476B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2015/095165 2015-11-20
CNPCT/CN2016/105043 2016-11-08
PCT/CN2016/106597 WO2017084629A1 (en) 2015-11-20 2016-11-21 Macrocyclic broad spectrum antibiotics

Publications (2)

Publication Number Publication Date
MX2018006199A MX2018006199A (es) 2019-01-10
MX387476B true MX387476B (es) 2025-03-18

Family

ID=58231314

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006199A MX387476B (es) 2015-11-20 2016-11-21 Antibióticos de amplio espectro macrocíclico.

Country Status (12)

Country Link
US (1) US11072635B2 (cg-RX-API-DMAC7.html)
EP (1) EP3377474B1 (cg-RX-API-DMAC7.html)
JP (1) JP6873993B2 (cg-RX-API-DMAC7.html)
KR (1) KR20180109858A (cg-RX-API-DMAC7.html)
CN (1) CN109219596B (cg-RX-API-DMAC7.html)
AU (1) AU2016357926B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018010267A2 (cg-RX-API-DMAC7.html)
CA (1) CA3005551A1 (cg-RX-API-DMAC7.html)
IL (1) IL259429B (cg-RX-API-DMAC7.html)
MX (1) MX387476B (cg-RX-API-DMAC7.html)
RU (1) RU2761476C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017084629A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
EP3145944B1 (en) 2014-05-20 2021-05-05 RQX Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
RU2761476C2 (ru) 2015-11-20 2021-12-08 АрКьюИкс ФАРМАСЬЮТИКЭЛС, ИНК. Макроциклические антибиотики широкого спектра действия
KR102671585B1 (ko) * 2017-02-15 2024-06-04 알큐엑스 파마슈티컬스, 인크. 거대환형 광범위 항생제
MA50664A (fr) * 2017-09-29 2020-08-05 Genentech Inc Complexes d'antibiotiques peptidiques et leurs méthodes d'utilisation
HRP20231497T8 (hr) * 2019-05-28 2024-08-02 F. Hoffmann-La Roche Ag Makrociklični antibiotici širokog spektra

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128280A (en) 1959-10-23 1964-04-07 Searle & Co 1-(alkoxylated/halogenated phenyl)-3-pyridylmethylureas
US5204328A (en) 1990-06-26 1993-04-20 Merck & Co., Inc. Peptides having atrial natriuretic factor activity
JPH11514527A (ja) 1995-11-03 1999-12-14 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー バキルス エスピー(Bacillus sp.)用の陽性選択ベクター
JP4080541B2 (ja) 1996-10-18 2008-04-23 バーテックス ファーマシューティカルズ インコーポレイテッド セリンプロテアーゼ、特にc型肝炎ウイルスns3プロテアーゼの阻害因子
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB9902399D0 (en) 1999-02-03 1999-03-24 Smithkline Beecham Plc Compounds
US6660832B1 (en) 1999-08-20 2003-12-09 Isis Pharmaceuticals, Inc. Macrocyclic compounds and preparation methods thereof
US6951840B2 (en) 2001-08-31 2005-10-04 Eli Lilly And Company Lipoglycopeptide antibiotics
DE10226921A1 (de) 2002-06-17 2003-12-24 Bayer Ag Antibakterielle Amid-Makrozyklen
EA010294B1 (ru) 2003-07-17 2008-08-29 Майджиникс, Инк. Композиции на основе производных липопептидных антибиотиков и способы их применения
DE10358824A1 (de) 2003-12-16 2005-07-21 Bayer Healthcare Ag Antibakterielle Makrozyklen mit substituiertem Biphenyl
DE102005014247A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen VI
DE102005014245A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen V
CA2791680A1 (en) 2010-03-01 2011-09-09 Myrexis, Inc. Compounds and therapeutic uses thereof
WO2011112441A1 (en) 2010-03-09 2011-09-15 Merck Sharp & Dohme Corp. Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials
WO2011120071A1 (en) 2010-04-01 2011-10-06 The University Of Queensland Oxytocin peptide analogues
WO2012036907A2 (en) 2010-09-15 2012-03-22 Romesberg Floyd E Broad spectrum antibiotic arylomycin analogs
TWI642684B (zh) 2011-05-27 2018-12-01 Rqx製藥股份有限公司 廣效性抗生素
US10501493B2 (en) 2011-05-27 2019-12-10 Rqx Pharmaceuticals, Inc. Broad spectrum antibiotics
CN103159830B (zh) 2011-12-15 2017-06-20 上海来益生物药物研究开发中心有限责任公司 脂肽类化合物
FR2986154B1 (fr) 2012-01-31 2017-08-04 Pierre Fabre Dermo Cosmetique Nouveau systeme photoprotecteur
CN104284664A (zh) * 2012-03-14 2015-01-14 斯克里普斯研究所 广谱抗生素Arylomycin类似物
CN103788176A (zh) * 2012-10-31 2014-05-14 上海来益生物药物研究开发中心有限责任公司 一种arylomycin类化合物及其制备方法和应用
BR112015011697A2 (pt) * 2012-11-21 2017-07-11 Rqx Pharmaceuticals Inc antibióticos macrocíclicos de amplo espectro
EP3145944B1 (en) 2014-05-20 2021-05-05 RQX Pharmaceuticals, Inc. Macrocyclic broad spectrum antibiotics
ITUB20154591A1 (it) 2015-10-12 2017-04-12 Crestoptics S R L Apparato di microscopia confocale e relativo procedimento di acquisizione ed elaborazione di immagini
RU2761476C2 (ru) 2015-11-20 2021-12-08 АрКьюИкс ФАРМАСЬЮТИКЭЛС, ИНК. Макроциклические антибиотики широкого спектра действия
TWI725075B (zh) * 2015-11-20 2021-04-21 美商Rqx製藥公司 巨環廣效抗生素
KR102671585B1 (ko) 2017-02-15 2024-06-04 알큐엑스 파마슈티컬스, 인크. 거대환형 광범위 항생제
ES2892173T3 (es) 2017-03-27 2022-02-02 Hoffmann La Roche Procedimiento para fabricar análogos de anillo de arilomicina
MA50664A (fr) 2017-09-29 2020-08-05 Genentech Inc Complexes d'antibiotiques peptidiques et leurs méthodes d'utilisation
HRP20231497T8 (hr) 2019-05-28 2024-08-02 F. Hoffmann-La Roche Ag Makrociklični antibiotici širokog spektra

Also Published As

Publication number Publication date
AU2016357926B2 (en) 2021-05-27
US20200239519A1 (en) 2020-07-30
US11072635B2 (en) 2021-07-27
JP2019501123A (ja) 2019-01-17
EP3377474C0 (en) 2023-08-16
JP6873993B2 (ja) 2021-05-19
CN109219596B (zh) 2022-04-19
KR20180109858A (ko) 2018-10-08
MX2018006199A (es) 2019-01-10
IL259429A (en) 2018-07-31
BR112018010267A2 (pt) 2018-11-27
AU2016357926A1 (en) 2018-06-14
CA3005551A1 (en) 2017-05-26
RU2018122498A3 (cg-RX-API-DMAC7.html) 2020-02-28
RU2018122498A (ru) 2019-12-26
CN109219596A (zh) 2019-01-15
WO2017084629A1 (en) 2017-05-26
EP3377474B1 (en) 2023-08-16
EP3377474A1 (en) 2018-09-26
RU2761476C2 (ru) 2021-12-08
IL259429B (en) 2021-12-01

Similar Documents

Publication Publication Date Title
MX2016015218A (es) Antibioticos macrociclicos de amplio espectro.
MX387476B (es) Antibióticos de amplio espectro macrocíclico.
BR112015011697A2 (pt) antibióticos macrocíclicos de amplo espectro
CO2019010001A2 (es) Antibióticos macrociclicos de amplio espectro
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
MX386742B (es) Antibióticos de amplio espectro macrocíclico.
CL2021003153A1 (es) Antibióticos macrocíclicos de amplio espectro
WO2015110969A3 (en) Nitrogen containing compounds and their use as antibacterial agents
PH12016501988A1 (en) Antibacterial compounds
WO2017218922A3 (en) Compositions and methods for the treatment of bacterial infections
PH12018500358A1 (en) Compounds for use in an antibacterial applications
HK1243951A1 (zh) 抗微生物组合和其在治疗微生物感染中的用途
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
MA39955A (fr) Compositions désinfectantes et antimicrobiennes, en particulier pour le domaine vétérinaire
PH12015500518A1 (en) Tricyclic tetrahydroquinoline antibacterial agents
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.
EA202091403A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EP3538094A4 (en) FORMULATIONS, METHODS, KIT AND PHARMACEUTICAL FORMS FOR TREATING BACTERIAL INFECTIONS
PL425328A1 (pl) Zastosowanie α,β-dihydroksantohumolu
CL2015001603A1 (es) Nuevos compuestos biciclicos y su uso como agentes antibacterianos e inhibidores de ß-lactamasa.
WO2017151625A8 (en) 4,9-dioxo-4,9-dihydronaphtho(2,3-b)furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases
JO3477B1 (ar) مركبات أحادي باكتام عضوية لعلاج العدوى البكتيرية
HK1241754A1 (en) Pulmonary administration of pyocins for treating bacterial respiratory infections
HK1228395A1 (en) Antibacterial compounds